In prostate adenocarcinoma (PCad), the downregulation of PKP1 in aggressive phenotypes is associated with enhanced proinflammatory cytokine stability, thereby fostering an immunosuppressive microenvironment that accelerates cancer progression (Breuninger et al., 2010; Yang et al., 2013; Kim et al., 2023). This evidence concerns the gene PKP1 and cancer.